Lataa...
Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy
BACKGROUND: Although IgA nephropathy (IgAN), an immune-mediated disease with heterogeneous clinical and pathological phenotypes, is the most common glomerulonephritis worldwide, it remains unclear which IgAN patients benefit from immunosuppression (IS) therapy. METHODS: Clinical and pathological dat...
Tallennettuna:
| Julkaisussa: | EBioMedicine |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7016365/ https://ncbi.nlm.nih.gov/pubmed/32062356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102657 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|